Quick Takeaways
- Neil Kumar filed SCHEDULE 13G/A for BridgeBio Pharma, Inc. Common Stock, par value $0.001 per share (BBIO).
- Disclosed ownership: 5.4%.
- Date of event: 31 Dec 2024.
Neil Kumar - 31 Dec 2024 SCHEDULE 13G/A Report for BridgeBio Pharma, Inc. Common Stock, par value $0.001 per share (BBIO)
- Filing Manager
- Neil Kumar
- Reporting Manager
- NEIL KUMAR
- Symbol
- BBIO
- Shares outstanding
- 193,469,723 shares
- Disclosed Ownership
- 10,466,712 shares
- Ownership
- 5.4%
- Form type
- SCHEDULE 13G/A
- Filing time
- 13 Feb 2025, 17:23:48 UTC
- Date of event
- 31 Dec 2024
- Next filing
- 16 Apr 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Neil Kumar disclosed 5.4% ownership in BridgeBio Pharma, Inc. Common Stock, par value $0.001 per share (BBIO) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 13 Feb 2025, 17:23.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| NEIL KUMAR | 5.4% | 10,466,712 | 3,772,579 | 6,694,133 | /s/ Neil Kumar | Neil Kumar |